The Gabelli Healthcare & Wellness Trust (GRX) is a publicly traded Financial Services sector company. As of May 21, 2026, GRX trades at $11.52 with a market cap of $131.76M and a P/E ratio of 0.00. GRX moved +0.78% today. Year to date, GRX is -6.05%; over the trailing twelve months it is -6.24%. Its 52-week range spans $8.90 to $11.15. Rallies surfaces GRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in GRX news today?
Gabelli Healthcare & WellnessRx Trust Declares $0.17 1Q Distribution Comprising 60% Return of Capital: Gabelli Healthcare & WellnessRx Trust’s board declared a $0.17 per share cash distribution payable March 24 to shareholders of record March 17, 2026. The 1Q distribution comprises roughly 2% net investment income, 38% net capital gains and 60% return of capital based on current accounting records.
GABELLI MARIO J bought 3.80K (~$36.40K) on Jan 12, 2026.
GABELLI MARIO J bought 1.01K (~$9.68K) on Jan 12, 2026.
GABELLI MARIO J bought 990 (~$9.48K) on Jan 8, 2026.
GRX Analyst Consensus
GRX analyst coverage data. Average price target: $0.00.
Common questions about GRX
What changed in GRX news today?
Gabelli Healthcare & WellnessRx Trust Declares $0.17 1Q Distribution Comprising 60% Return of Capital: Gabelli Healthcare & WellnessRx Trust’s board declared a $0.17 per share cash distribution payable March 24 to shareholders of record March 17, 2026. The 1Q distribution comprises roughly 2% net investment income, 38% net capital gains and 60% return of capital based on current accounting records.
Does Rallies summarize GRX news?
Yes. Rallies summarizes GRX news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is GRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GRX. It does not provide personalized investment advice.
